PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
08-Apr-2020 Almac Clinical Technologies Announces Expedited Support for COVID-19 Clinical Trials Almac Group
08-Apr-2020 COVID-19: BOLLORÉ LOGISTICS RECEIVES 92 TONS OF PROTECTIVE MASKS AND MEDICAL EQUIPMENT FROM CHINA AT THE GENEVA AIRPORT Bolloré Logistics
07-Apr-2020 Harrogate Convention Centre and the new Nightingale Hospital Harrogate Convention Centre
07-Apr-2020 Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline Servier
07-Apr-2020 Availability of Transgene’s 2019 Universal Registration Document and update on the effect of Covid-19 Transgene
07-Apr-2020 EIB Group moves to scale up economic response to COVID-19 crisis European Investment Bank (EIB)
07-Apr-2020 World’s leading Biobanks join BC Platforms Global DataPartner Network to Advance Personalized Healthcare Research BC Platforms
07-Apr-2020 Covid-19: Oxford University spin-out develops new AI tech platform to analyse Covid-19 x-rays to speed up Zegami
07-Apr-2020 Shorter radiotherapy treatment for bowel cancer patients during COVID-19 University of Leeds
07-Apr-2020 First-in-class cholesterol-lowering treatment NILEMDO®▼ (bempedoic acid) and NUSTENDI®▼ (bempedoic acid / Ezetimibe) approved in Europe Daiichi Sankyo Europe GmbH
07-Apr-2020 RedHill Biopharma Announces Approval of Compassionate Use of Opaganib for COVID-19 in Italy RedHill Biopharma Ltd.
07-Apr-2020 BillionToOne announces groundbreaking new COVID-19 test to unlock 1 million daily tests. BillionToOne
07-Apr-2020 Domino Supports Vital Sectors in Current Crisis Domino
07-Apr-2020 Nuance Announces Free COVID-19 Documentation Templates for all Dragon Medical Users and Mobile Solutions for Care Teams Nuance® Communications, Inc
07-Apr-2020 CluePoints Launches Complimentary COVID-19 Risk Management Package for Clinical Studies CluePoints
07-Apr-2020 CARMAT confirms the definitive approval of its "Forfait Innovation" dossier by the French National Authority for Health (HAS) CARMAT
07-Apr-2020 Sanofi successfully prices taps on outstanding bond issues for EUR 500 million Sanofi
07-Apr-2020 Sanofi finalizes Praluent® (alirocumab) restructuring with Regeneron Sanofi
07-Apr-2020 Exosome Research Collaboration ReNeuron Group plc
07-Apr-2020 Amphista Therapeutics raises $7.5m Series A round to advance targeted protein degradation assets in cancer Amphista Therapeutics